ClinConnect ClinConnect Logo
Search / Trial NCT06179797

Chronic Remote Ischemic Conditioning in Vascular Cognitive Impairment: A Dose Escalation Study

Launched by AUGUSTA UNIVERSITY · Dec 12, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a treatment called remote ischemic conditioning, which involves temporarily restricting blood flow to an arm to see how it affects brain health and cognitive function in older adults. The goal is to learn how different doses of this treatment influence certain blood markers related to brain health in people who have age-related changes in their brain's white matter, as seen on MRI scans. This study is important as it will help researchers prepare for a larger trial to see if this treatment can help improve cognitive function.

To be eligible for the trial, participants need to be at least 55 years old and have had an MRI in the past six months showing only mild to moderate age-related brain changes. They should be able to walk independently and perform daily activities without assistance. Participants will be asked to use a special device during the treatment, and they will need to understand the study and give their consent to take part. If you're interested in helping with this important research, this trial offers a chance to contribute to our understanding of brain health in aging.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥55 years
  • 2. Head MRI in the past 6 months showing no more than moderate age related cerebral white matter changes (Fazekas score 0-2).
  • 3. Able to walk without assistance \& independently perform basic activities of daily living.
  • 4. Able to understand this study and agree for a valid consent.
  • Exclusion Criteria:
  • Prior non-lacunar (cortical) stroke. 2. Unable to cooperate with the use of the conditioning device. 3. Confounding illness that might interfere with the interpretation of results (such as active malignancy or multiple sclerosis).
  • 4. Contraindication to transient arm ischemia in either arm (such as symptomatic peripheral artery disease).

About Augusta University

Augusta University is a prominent academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a leader in medical education and patient care, Augusta University conducts rigorous clinical studies aimed at improving treatment outcomes and enhancing patient quality of life. The university’s commitment to interdisciplinary collaboration fosters a dynamic research environment, enabling the exploration of novel therapies and interventions across a wide range of medical fields. With a focus on ethical standards and patient safety, Augusta University strives to translate scientific discoveries into tangible benefits for the community and beyond.

Locations

Augusta, Georgia, United States

Patients applied

0 patients applied

Trial Officials

Carol Smith, RN

Study Director

Wellstar MCG Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported